Loading
We have very little insider data for Medytox Solutions, Inc. so far: the most recent filing dates from 10 May 2016. With so few records, no pattern can be drawn yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
7 of 7 declarations
Medytox Solutions, Inc. is a company listed on the XNAS market, specializing in the development of innovative solutions in the healthcare sector. It focuses on the research and commercialization of biological and pharmaceutical products.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2014 | 77.2 m USD | 2.8 m USD | 0.09 USD | 10-K |
| Dec 2013 | 52.5 m USD | 5.7 m USD | 0.19 USD | 10-K |
| Dec 2012 | 21.1 m USD | 2.3 m USD | n.d. | 10-K |
| Dec 2011 | 4.0 m USD | 586,795 USD | n.d. | 10-K |
| Dec 2010 | 77,591 USD | -327,041 USD | n.d. | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.